The Turkish Guideline for the Diagnosis and Management of Urticaria-2016

Background and Design: Albeit an easily recognized disease, urticaria features many diverse approaches which rationalize the need for an algorithm for the diagnosis, classification, etiopathogenesis, diagnostic evaluation and therapeutic approach. Therefore, authors from Dermatoallergy Working Group of the Turkish Society of Dermatology and the Turkish Dermatoimmunology and Allergy Association aimed to create an urticaria guideline for the diagnosis, treatment and follow-up of urticaria. Materials and Methods: Each section of the guideline has been written by a different author. The prepared sections were evaluated in part by e-mail correspondence and have taken its final form after revision in the last meeting held by the participation of all authors. Results: The guideline includes the description, classification, pathophysiology as well as diagnosis and treatment of urticaria. Urticaria is classified into two main types: acute urticaria and chronic urticaria while chronic urticaria is further subdivided into spontaneous urticaria and inducible urticaria. The first step of treatment includes standard doses of H1-blockers. In patients who do not respond to the first step, antihistamine dose is increased up to four times; if unsuccessful, another second-generation antihistamine is given in the same dose. In antihistamine-resistant cases, introduction of omalizumab is required. Omalizumab dose may be increased in patients failing to respond to the standard dose. In patients unresponsive to omalizumab, cyclosporine-A may be given. Routine diagnostic tests are not recommended in acute urticaria. In chronic urticaria, erythrocyte sedimentation rate, differential blood count and C-reactive protein testing are the only investigations that are needed routinely. Conclusion: Chronic urticaria is a disease that can be challenging for the physician in terms of treatment and follow-up. Depending on evidence-based data (and individual experiences), this guideline will have a leading role in the diagnosis and treatment of urticaria and help the physician to overcome the challenges in the management.

Yazar Goncu, Emek Kocaturk
Aktan, Sebnem
Atakan, Nilgun
Baskan, Emel Bulbul
Erdem, Teoman
Koca, Rafet
Savk, Ekin
Yayın Türü Article
Tek Biçim Adres https://hdl.handle.net/20.500.12628/3683
Tek Biçim Adres 10.4274/turkderm.22438
Konu Başlıkları Acute urticaria
algorithm
angioedema
chronic idiopathic urticaria
chronic spontaneous urticaria
guideline
physical urticaria
treatment urticaria
Turkey
Koleksiyonlar Araştırma Çıktıları | WoS | Scopus | TR-Dizin | PubMed | SOBİAD
WoS İndeksli Yayınlar Koleksiyonu
Dergi Adı TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY
Dergi Cilt Bilgisi 50
Dergi Sayısı 3
Sayfalar 82 - 98
Yayın Yılı 2016
Eser Adı
[dc.title]
The Turkish Guideline for the Diagnosis and Management of Urticaria-2016
Yazar
[dc.contributor.author]
Goncu, Emek Kocaturk
Yazar
[dc.contributor.author]
Aktan, Sebnem
Yazar
[dc.contributor.author]
Atakan, Nilgun
Yazar
[dc.contributor.author]
Baskan, Emel Bulbul
Yazar
[dc.contributor.author]
Erdem, Teoman
Yazar
[dc.contributor.author]
Koca, Rafet
Yazar
[dc.contributor.author]
Savk, Ekin
Yayın Yılı
[dc.date.issued]
2016
Yayıncı
[dc.publisher]
DERI ZUHREVI HASTALIKLAR DERNEGI
Yayın Türü
[dc.type]
article
Özet
[dc.description.abstract]
Background and Design: Albeit an easily recognized disease, urticaria features many diverse approaches which rationalize the need for an algorithm for the diagnosis, classification, etiopathogenesis, diagnostic evaluation and therapeutic approach. Therefore, authors from Dermatoallergy Working Group of the Turkish Society of Dermatology and the Turkish Dermatoimmunology and Allergy Association aimed to create an urticaria guideline for the diagnosis, treatment and follow-up of urticaria. Materials and Methods: Each section of the guideline has been written by a different author. The prepared sections were evaluated in part by e-mail correspondence and have taken its final form after revision in the last meeting held by the participation of all authors. Results: The guideline includes the description, classification, pathophysiology as well as diagnosis and treatment of urticaria. Urticaria is classified into two main types: acute urticaria and chronic urticaria while chronic urticaria is further subdivided into spontaneous urticaria and inducible urticaria. The first step of treatment includes standard doses of H1-blockers. In patients who do not respond to the first step, antihistamine dose is increased up to four times; if unsuccessful, another second-generation antihistamine is given in the same dose. In antihistamine-resistant cases, introduction of omalizumab is required. Omalizumab dose may be increased in patients failing to respond to the standard dose. In patients unresponsive to omalizumab, cyclosporine-A may be given. Routine diagnostic tests are not recommended in acute urticaria. In chronic urticaria, erythrocyte sedimentation rate, differential blood count and C-reactive protein testing are the only investigations that are needed routinely. Conclusion: Chronic urticaria is a disease that can be challenging for the physician in terms of treatment and follow-up. Depending on evidence-based data (and individual experiences), this guideline will have a leading role in the diagnosis and treatment of urticaria and help the physician to overcome the challenges in the management.
Açıklama
[dc.description]
WOS: 000388299400002
Kayıt Giriş Tarihi
[dc.date.accessioned]
2019-12-23
Açık Erişim Tarihi
[dc.date.available]
2019-12-23
Yayın Dili
[dc.language.iso]
tur
Konu Başlıkları
[dc.subject]
Acute urticaria
Konu Başlıkları
[dc.subject]
algorithm
Konu Başlıkları
[dc.subject]
angioedema
Konu Başlıkları
[dc.subject]
chronic idiopathic urticaria
Konu Başlıkları
[dc.subject]
chronic spontaneous urticaria
Konu Başlıkları
[dc.subject]
guideline
Konu Başlıkları
[dc.subject]
physical urticaria
Konu Başlıkları
[dc.subject]
treatment urticaria
Konu Başlıkları
[dc.subject]
Turkey
Haklar
[dc.rights]
info:eu-repo/semantics/openAccess
ISSN
[dc.identifier.issn]
1019-214X
ISSN
[dc.identifier.issn]
1308-6294
İlk Sayfa Sayısı
[dc.identifier.startpage]
82
Son Sayfa Sayısı
[dc.identifier.endpage]
98
Dergi Adı
[dc.relation.journal]
TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY
Dergi Sayısı
[dc.identifier.issue]
3
Dergi Cilt Bilgisi
[dc.identifier.volume]
50
Tek Biçim Adres
[dc.identifier.uri]
https://dx.doi.org/10.4274/turkderm.22438
Tek Biçim Adres
[dc.identifier.uri]
https://hdl.handle.net/20.500.12628/3683
Görüntülenme Sayısı ( Şehir )
Görüntülenme Sayısı ( Ülke )
Görüntülenme Sayısı ( Zaman Dağılımı )
Görüntülenme
13
09.12.2022 tarihinden bu yana
İndirme
1
09.12.2022 tarihinden bu yana
Son Erişim Tarihi
08 Şubat 2024 09:00
Google Kontrol
Tıklayınız
urticaria treatment guideline diagnosis patients chronic includes Turkish standard follow-up omalizumab increased authors physician disease respond diagnostic classification antihistamine Omalizumab required introduction antihistamine-resistant second-generation another unsuccessful failing Background unresponsive experiences) Depending evidence-based individual leading overcome
6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve çerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms